Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

892 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis.
Guler S, Sarbu AC, Stalder O, Allanore Y, Bernardino V, Distler J, Gabrielli A, Hoffmann-Vold AM, Matucci-Cerinic M, Müller-Ladner U, Ortiz-Santamaria V, Rednic S, Riccieri V, Smith V, Ullman S, Walker UA, Geiser TK, Distler O, Maurer B, Kollert F. Guler S, et al. Thorax. 2023 Dec;78(12):1188-1196. doi: 10.1136/thorax-2023-220541. Epub 2023 Oct 5. Thorax. 2023. PMID: 37798114
Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort.
Colalillo A, Pellicano C, Ananyeva LP, Hachulla E, Cuomo G, Györfi AH, Czirják L, de Vries-Bouwstra J, Mouthon L, Poormoghim H, Del Galdo F, Hunzelmann N, Spierings J, Kuwana M, Rosato E; and the EUSTAR Collaborators. Colalillo A, et al. Arthritis Care Res (Hoboken). 2023 Jul 17. doi: 10.1002/acr.25196. Online ahead of print. Arthritis Care Res (Hoboken). 2023. PMID: 37458105 Free article.
The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune-Mediated Inflammatory Disease.
Müller-Ladner U, Dignass A, Gaffney K, Jadon D, Matucci-Cerinic M, Lobaton T, Carron P, Gisbert JP, Pande I, Utzinger M, Addison J. Müller-Ladner U, et al. BioDrugs. 2023 Nov;37(6):873-889. doi: 10.1007/s40259-023-00616-3. Epub 2023 Aug 26. BioDrugs. 2023. PMID: 37632666 Free PMC article. Clinical Trial.
The phenotype of mixed connective tissue disease patients having associated interstitial lung disease.
Boleto G, Reiseter S, Hoffmann-Vold AM, Mirouse A, Cacoub P, Matucci-Cerinic M, Silvério-António M, Fonseca JE, Duarte AC, Pestana Lopes J, Riccieri V, Lescoat A, Le Tallec E, Castellví Barranco I, Tandaipan JL, Airó P, Kuwana M, Kavosi H, Avouac J, Allanore Y. Boleto G, et al. Semin Arthritis Rheum. 2023 Dec;63:152258. doi: 10.1016/j.semarthrit.2023.152258. Epub 2023 Aug 26. Semin Arthritis Rheum. 2023. PMID: 37696231
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology.
De Angelis R, Ferri C, Giuggioli D, Bajocchi G, Dagna L, Bellando-Randone S, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Lepri G, Girelli F, Riccieri V, Zanatta E, Bosello SL, Cavazzana I, Ingegnoli F, De Santis M, Murdaca G, Abignano G, Romeo N, Della Rossa A, Caminiti M, Iuliano AM, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Cipolletta E, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Di Vico C, Gigante A, Pellagrino G, Pigatto E, Lazzaroni MG, Franceschini F, Generali E, Mennillo G, Barsotti S, Mariano GP, Furini F, Vultaggio L, Parisi S, Peroni CL, Rozza D, Zanetti A, Carrara G, Landolfi G, Scirè CA, Bianchi G, Fusaro E, Sebastiani GD, Govoni M, D'Angelo S, Cozzi F, Guiducci S, Doria A, Salvarani C, Iannone F, Matucci-Cerinic M; SPRING-SIR (Systemic Sclerosis PRogression INvestiGation group of the Italian Society of Rheumatology). De Angelis R, et al. RMD Open. 2023 Mar;9(1):e002890. doi: 10.1136/rmdopen-2022-002890. RMD Open. 2023. PMID: 36868782 Free PMC article.
Investigational drugs for the treatment of scleroderma: what's new?
Colic J, Campochiaro C, Hughes M, Matucci Cerinic M, Dagna L. Colic J, et al. Expert Opin Investig Drugs. 2023 Jul-Dec;32(7):601-614. doi: 10.1080/13543784.2023.2242762. Epub 2023 Aug 8. Expert Opin Investig Drugs. 2023. PMID: 37526079 Review.
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production.
Cantoni E, Merelli I, Stefanoni D, Tomelleri A, Campochiaro C, Giordano V, Panigada M, Baldissera EM, Merlo Pich L, Natoli V, Ziogas A, Domínguez-Andrés J, De Luca G, Mazza D, Zambrano S, Gnani D, Ferrarini M, Ferrero E, Agresti A, Vergani B, Leone BE, Cenci S, Ravelli A, Matucci-Cerinic M, D'Alessandro A, Joosten LAB, Dagna L, Netea MG, Molteni R, Cavalli G. Cantoni E, et al. Rheumatology (Oxford). 2023 Oct 3;62(10):3469-3479. doi: 10.1093/rheumatology/kead061. Rheumatology (Oxford). 2023. PMID: 36802235
892 results